Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. First observed

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare read-only/idempotent/non-destructive; description adds critical behavior: pulls SEC EDGAR/XBRL 10-K data, handles off-calendar fiscal years, sorts results by primary metric, returns paired data with pipeworx:// citation URIs. No contradiction.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Dense but efficient—starts with trigger phrases, then core function, then type-specific data, sorting, and return format. Every sentence adds new information; no redundancy or padding.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With only 2 params and no output schema, the description fully covers input semantics, output structure (paired data + citation URIs), sorting behavior, data sources, and edge-case handling (off-calendar fiscal years). Sufficient for an agent to invoke correctly without further clarification.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema covers both parameters with 100% descriptions. Description adds value by detailing what each type selects (company→10-K financials, drug→FAERS/FDA/trial counts) and gives concrete examples (AAPL/MSFT, ozempic/mounjaro) plus sorting behavior. Minor gap: doesn't specify exact input formatting for drug names beyond examples.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

Clear verb+resource: side-by-side comparison of 2–5 companies or drugs. Trigger phrases ("X vs Y", "rank these companies") anchor intent, and the explicit "ALWAYS PREFER over sequential single-pack lookups" distinguishes it from single-entity tools like entity_profile.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

States exactly when to use: "ALWAYS PREFER over sequential single-pack lookups when comparing entities." Provides query examples and differentiates company vs drug type, plus what data each returns. Also notes it replaces 8–15 sequential lookups, guiding cost/latency decisions.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation2/5

Several tools are easy to confuse: ask_pipeworx_beta is currently identical to ask_pipeworx, deep_research overlaps heavily with ask_pipeworx/ask_pipeworx_grounded, and the six polymarket_* tools have closely related purposes. ai_visibility_check and scan_competitor_ai_presence also overlap, making selection error-prone.

Naming Consistency4/5

Almost all tools use lowercase snake_case and mostly follow a verb_noun pattern (query_layer, resolve_entity, scan_dependency, validate_claim). A few noun-style names like entity_profile, layer_info, and pipeworx_trending deviate slightly, but the overall convention is predictable.

Tool Count2/5

34 tools is well past the heavy threshold, and the server is named 'Arcgis Charlotte' while only three tools actually relate to ArcGIS. The rest form a sprawling Pipeworx research, prediction-market, subscription, and memory toolkit, which creates a severe scope mismatch.

Completeness2/5

For the Pipeworx data side the surface is quite thorough, but for the declared ArcGIS Charlotte purpose it is thin: search_datasets, layer_info, and query_layer provide read-only access with no update/delete, analysis, or dataset management. The tool set therefore has a significant gap relative to its stated domain.